From Jilin University.
Highly dedicated medical research scientist with a strong focus on hepatology and immunology, specializing in hepatocellular carcinoma (HCC) and liver immunity. Proven ability to contribute to significant scientific publications, leveraging advanced methodologies like deep learning to predict patient outcomes and identify predictive biomarkers. Committed to advancing understanding and therapeutic strategies for complex liver diseases.
Published by
Hepatology
Summary
Contributed to a letter detailing technical considerations for developing a multimodal deep learning model, aimed at improving the prediction of hepatocellular carcinoma (HCC) outcomes.
Published by
Frontiers in Immunology
Summary
Co-authored research investigating the predictive significance of peripheral blood CD4+ T and NK cells in assessing immunotherapy efficacy and long-term survival for patients with advanced hepatocellular carcinoma (HCC).
Published by
Zhonghua gan zang bing za zhi = Chinese journal of hepatology
Summary
Co-authored a study evaluating the accuracy and utility of the ALBI grade for precise estimation of liver reserve function in patients diagnosed with hepatocellular carcinoma (HCC).
Scientific Research, Data Interpretation, Statistical Analysis, Deep Learning, Multimodal Modeling, Biomarker Discovery, Predictive Analytics, Immunology Research, Hepatology Research.
Hepatocellular Carcinoma (HCC), Liver Immunity, NK Cells, CD4+ T Cells, Immunotherapy, Oncology, Liver Disease, ALBI Grade, Cancer Biology.
Scientific Writing, Journal Publication, Peer Review, Academic Collaboration.